These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23199742)

  • 1. The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent.
    Yang J; Zeng Y; Zhang C; Chen YX; Yang Z; Li Y; Leng X; Kong D; Wei XQ; Sun HF; Song CX
    Biomaterials; 2013 Feb; 34(6):1635-43. PubMed ID: 23199742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
    Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilayered Nanoparticles with Sequential Release of VEGF Gene and Paclitaxel for Restenosis Inhibition in Atherosclerosis.
    Zhu X; Xie H; Liang X; Li X; Duan J; Chen Y; Yang Z; Liu C; Wang C; Zhang H; Fang Q; Sun H; Li C; Li Y; Wang C; Song C; Zeng Y; Yang J
    ACS Appl Mater Interfaces; 2017 Aug; 9(33):27522-27532. PubMed ID: 28748694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery.
    Wessely R; Blaich B; Belaiba RS; Merl S; Görlach A; Kastrati A; Schömig A
    Thromb Haemost; 2007 Jun; 97(6):1003-12. PubMed ID: 17549304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.
    Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH
    J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
    Zhao FH; Chen YD; Jin ZN; Lu SZ
    Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An electrospun fiber-covered stent with programmable dual drug release for endothelialization acceleration and lumen stenosis prevention.
    Zhang Y; Wang J; Xiao J; Fang T; Hu N; Li M; Deng L; Cheng Y; Zhu Y; Cui W
    Acta Biomater; 2019 Aug; 94():295-305. PubMed ID: 31195144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release of paclitaxel from heparinized metal stent fabricated by layer-by-layer assembly of polylysine and hyaluronic acid-g-poly(lactic-co-glycolic acid) micelles encapsulating paclitaxel.
    Kim TG; Lee H; Jang Y; Park TG
    Biomacromolecules; 2009 Jun; 10(6):1532-9. PubMed ID: 19361215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release of paclitaxel using a drug-eluting stent through modulation of the size of drug particles in vivo.
    Jang BN; Kang SN; Eom TG; Han DK; An SH; Noh I; Kum CH
    J Biomed Mater Res B Appl Biomater; 2018 Aug; 106(6):2275-2283. PubMed ID: 29087014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelialization of sirolimus-eluting stents with slow and extended drug release in the porcine overstretch model.
    Frey D; Billinger M; Meier P; Beslac O; Grossenbacher R; Hänni B; Hess OM
    J Invasive Cardiol; 2008 Dec; 20(12):631-4. PubMed ID: 19057024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel polymer-free paclitaxel-eluting stent with a nanoporous surface for rapid endothelialization and inhibition of intimal hyperplasia: Comparison with a polymer-based sirolimus-eluting stent and bare metal stent in a porcine model.
    Jia H; Liu H; Kong J; Hou J; Wu J; Zhang M; Tian J; Liu H; Ma L; Hu S; Huang X; Zhang S; Zhang S; Yu B; Jang IK
    J Biomed Mater Res A; 2011 Sep; 98(4):629-37. PubMed ID: 21732525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cell recovery between comparator polymer-based drug-eluting stents.
    Joner M; Nakazawa G; Finn AV; Quee SC; Coleman L; Acampado E; Wilson PS; Skorija K; Cheng Q; Xu X; Gold HK; Kolodgie FD; Virmani R
    J Am Coll Cardiol; 2008 Jul; 52(5):333-42. PubMed ID: 18652940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents.
    Chieffo A; Foglieni C; Nodari RL; Briguori C; Sangiorgi G; Latib A; Montorfano M; Airoldi F; Michev I; Carlino M; Colombo A; Maseri A
    Am J Cardiol; 2009 Dec; 104(12):1660-7. PubMed ID: 19962471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
    van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations.
    Richard R; Schwarz M; Chan K; Teigen N; Boden M
    J Biomed Mater Res A; 2009 Aug; 90(2):522-32. PubMed ID: 18563805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimusand tacrolimus-eluting stents.
    van Beusekom HM; Sorop O; van den Heuvel M; Onuma Y; Duncker DJ; Danser AH; van der Giessen WJ
    EuroIntervention; 2010 May; 6(1):117-25. PubMed ID: 20542807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model.
    Salu KJ; Bosmans JM; Huang Y; Hendriks M; Verhoeven M; Levels A; Cooper S; De Scheerder IK; Vrints CJ; Bult H
    Cardiovasc Res; 2006 Feb; 69(2):536-44. PubMed ID: 16386237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.